Clinical Trial Update: Qatar Cardiometabolic Retrospective Cohort-Analysis Using Artificial Intelligence

View source ↗

Summary

A retrospective cohort analysis leveraging artificial intelligence is planned in Qatar to study cardiometabolic conditions; the study is sponsored by Weill Corn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Coronary Syndrome
• Prediabetes
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Weill Cornell Medical College in Qatar | Conditions: Cardio Vascular Disease, Acute Coronary Syndromes (ACS) | Status: NOT_YET_RECRUITING